The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin
Open accessAbstract
Development of parameters for the fabrication of nanosized vectors is pivotal for its successful administration in therapeutic applications. In this study, homogeneously distributed chitosan nanoparticles (CNPs) with diameters as small as 62 nm and a polydispersity index (PDI) of 0.15 were synthesized and purified using a simple, robust method that was highly reproducible. Nanoparticles were synthesized using modified ionic gelation of the chitosan polymer with sodium tripolyphosphate. Using this method, larger aggregates were mechanically isolated from single particles in the nanoparticle population by selective efficient centrifugation. The presence of disaggregated monodisperse nanoparticles was confirmed using atomic force microscopy. Factors such as anions, pH, and concentration were found to affect the size and stability of nanoparticles directly. The smallest nanoparticle population was ∼62 nm in hydrodynamic size, with a low PDI of 0.15, indicating high particle homogeneity. CNPs were highly stable and retained their monodisperse morphology in serum-supplemented media in cell culture conditions for up to 72 hours, before slowly degrading over 6 days. Cell viability assays demonstrated that cells remained viable following a 72-hour exposure to 1 mg/mL CNPs, suggesting that the nanoparticles are well tolerated and highly suited for biomedical applications. Cellular uptake studies using fluorescein isothiocyanate-labeled CNPs showed that cancer cells readily accumulate the nanoparticles 30 minutes posttreatment and that nanoparticles persisted within cells for up to 24 hours posttreatment. As a proof of principle for use in anticancer therapeutic applications, a [(14)C]-radiolabeled form of the anticancer agent doxorubicin was efficiently encapsulated within the CNP, confirming the feasibility of using this system as a drug delivery vector.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers
Calvo, P., Remu��n-L�pez, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Journal of Applied Polymer Science · doi:10.1002/(sici)1097-4628(19970103)63:1<125::aid-app13>3.0.co;2-4 · Cited by 1,856
Preparation and antibacterial activity of chitosan nanoparticles
Qi, L., Xu, Z., Jiang, X., Hu, C., & Zou, X. (2004) · Carbohydrate Research · doi:10.1016/j.carres.2004.09.007 · Cited by 1,804
Chitosan nanoparticles as delivery systems for doxorubicin
Janes, K. A., Fresneau, M. P., Marazuela, A., Fabra, A., & Alonso, M. J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00294-2 · Cited by 721
Mitra, S., Gaur, U., Ghosh, P. C., & Maitra, A. N. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00342-x · Cited by 647
Development and characterisation of chitosan nanoparticles for siRNA delivery
Katas, H., & Alpar, H. O. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.021 · Cited by 642
Shu, X. Z., & Zhu, K. J. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00403-8 · Cited by 423
Anitha, A., Divya Rani, V. V., Krishna, R., Sreeja, V., Selvamurugan, N., Nair, S. V., Tamura, H., & Jayakumar, R. (2009) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2009.05.028 · Cited by 419
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin
Park, J., Fong, P. M., Lu, J., Russell, K. S., Booth, C. J., Saltzman, W. M., & Fahmy, T. M. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.02.002 · Cited by 339
Bioadhesive chitosan nanoparticles: Preparation and characterization
Dudhani, A. R., & Kosaraju, S. L. (2010) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2010.02.026 · Cited by 335
Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels
Krasnici, S., Werner, A., Eichhorn, M. E., Schmitt‐Sody, M., Pahernik, S. A., Sauer, B., Schulze, B., Teifel, M., Michaelis, U., Naujoks, K., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11108 · Cited by 313
Cited by
Drug release study of the chitosan-based nanoparticles
Herdiana, Y., Wathoni, N., Shamsuddin, S., & Muchtaridi, M. (2022) · Heliyon · doi:10.1016/j.heliyon.2021.e08674 · Cited by 576
Cholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molecule
Kaddah, S., Khreich, N., Kaddah, F., Charcosset, C., & Greige-Gerges, H. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.01.017 · Cited by 308
Momin, M. Y., Gaddam, R. R., Kravitz, M., Gupta, A., & Vikram, A. (2021) · Cells · doi:10.3390/cells10113097 · Cited by 107
Deep Eutectic Solvent Assisted Dispersion of Carbon Nanotubes in Water
Zaib, Q., Adeyemi, I., Warsinger, D. M., & AlNashef, I. M. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00808 · Cited by 29
Metadata
- Authors
- Masarudin, M. J., Cutts, S. M., Evison, B. J., Phillips, D. R., & Pigram, P. J.
- Venue
- Nanotechnology, Science and Applications
- Publisher
- Informa UK Limited
- Published
- 2015-12
- Volume
- 8
- Pages
- 67
- ISSN
- 1177-8903 (ISSN-L)
- OpenAlex
- W2205810849
- Cited by
- 342
- References
- 22
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin. https://app.cochat.ai/papers/10.2147/nsa.s91785
- The paper
- Masarudin, M. J., Cutts, S. M., Evison, B. J., Phillips, D. R., & Pigram, P. J. (2015). Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin. Nanotechnology, Science and Applications. https://doi.org/10.2147/nsa.s91785
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.